Neurocrine Biosciences (NBIX) EPS (Basic) (2010 - 2026)
Neurocrine Biosciences (NBIX) posted EPS (Basic) of $1.97 for Q1 2026, up 27.48% on a QoQ basis from $1.54 in Q4 2025, and up 2385.12% year-over-year from $0.08 in Q1 2025.
Neurocrine Biosciences (NBIX) EPS (Basic) (2010 - 2026) Analysis & Trends
Neurocrine Biosciences' EPS (Basic) history runs 17 years deep, the most recent figure standing at $1.97 for Q1 2026.
- Quarterly EPS (Basic) rose 2385.12% year-over-year to $1.97 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.65 (up 116.9% YoY) and the FY2025 annual result came in at $4.81, up 41.5% from the prior year.
- EPS (Basic) was $1.97 for Q1 2026 at Neurocrine Biosciences, up from $1.54 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.11 in Q3 2025 and bottomed at -$0.79 in Q1 2023.
- A 5-year average of $0.84 and a median of $0.93 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 640.86% — and 2026, when it surged 2385.12%.
- Neurocrine Biosciences' EPS (Basic) stood at $0.93 in 2022, then jumped by 62.73% to $1.51 in 2023, then tumbled by 32.07% to $1.03 in 2024, then jumped by 50.43% to $1.54 in 2025, then grew by 27.48% to $1.97 in 2026.
- Business Quant data shows NBIX's EPS (Basic) at $1.97 in Q1 2026, $1.54 in Q4 2025, and $2.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 |
| Dec 31, 2025 | 1.54 |
| Sep 30, 2025 | 2.11 |
| Jun 30, 2025 | 1.09 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 1.03 |
| Sep 30, 2024 | 1.28 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 1.51 |
| Sep 30, 2023 | 0.85 |
| Jun 30, 2023 | 0.98 |
| Mar 31, 2023 | -0.79 |
| Dec 31, 2022 | 0.93 |
| Sep 30, 2022 | 0.72 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | -0.08 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.45 |